ABBV Abbvie Inc.
Five-factor quant read, peer ranking, and the analyst team's own call.
priced for 10.4% growth vs 1.8% delivered · -42% to base-case fair value
Piotroski 6/8 · Altman grey zone · ROE -129% · interest covered 3x
shallow recent drawdowns · pressing its 52-week high
Descriptive, not predictive. Momentum, Defensive and Tactical are deciles within our liquid universe; Value and Quality are computed from filed financials. None of them forecasts a return - the model's out-of-sample AUC is published in the whitepaper. Deciles as of 2026-09-02.
Peer comparison
Composite score against sector peers · 5 names
ABBV ranks #5 of 5 · peer average 6.4
Automated, educational research - not investment advice, and not a recommendation to buy or sell any security.